SBEV SBEV
Company Profile ↓Company Overview
SBEV (SBEV) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Return on capital employed stands at 92.8%.
Recent Developments
- Dec 2025 Revenue of $73.07K (-90.9% YoY); net profit $-25.23M.
- Trailing 12 Months Year-on-year growth — revenue -90.9%.
- 5-Year Trend Long-term compounding — revenue CAGR -14.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -14.45% |
| 1 Year: | -90.88% |
Stock Price Performance
| 1 Year: | -94.87% |
| 6 Months: | -81.59% |
| 3 Months: | -60.06% |
| 1 Month: | -33.59% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)45.69 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Healthy ROCE of 92.8%.
CONS
- Revenue declined at -14.4% CAGR over 5 years.
- Trading 95.8% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2013 | Jun 2013 | Sep 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 692.97K | - | - | 2.83M | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 44.33K | 41.52K | 63.33K | 84.61K | 83.67K | 85.96K | 119.91K | 86.06K | 100.03K | 133.34K | 122.49K | 122.49K | 104.54K | 121.72K | 170.35K | 174.45K | 207.73K | 165.08K | -10.44K | -5.44K | -13.95K | 4.79K | 193.98K | 343.94K | 517.42K | 905.05K | 819.85K | 1.29M | 1.35M | 1.77M | 1.76M | 1.78M | 1.30M | 163.62K | 244.43K | 291.02K | 25.54K | - | - | 1.85K |
| Operating Income | -5.59K | -5.97K | -10.01K | 15.37K | -2.52K | -6.18K | 254 | -15.92K | -19.77K | 11.79K | -12.23K | -12.23K | -61.24K | -21.59K | 33.07K | 15.95K | 68.48K | -2.21K | -448.48K | -308.15K | -861.60K | -1.55M | -415.48K | -2.16M | -4.55M | -6.71M | -12.07M | -5.68M | -5.83M | -5.11M | -3.45M | -4.22M | -4.32M | -3.25M | -3.69M | -2.67M | -1.66M | -1.63M | -9.54M | -978.97K |
| Net Income | -6.17K | -7.04K | -11.16K | 14.42K | -5.10K | -6.64K | -883 | -15.55K | -18.92K | 12.08K | -11.85K | -11.85K | -61.92K | -19.13K | 35.41K | 20.01K | 67.71K | -4.99K | -703.62K | -218.39K | -53.98K | -3.45M | -373.35K | -2.08M | -4.44M | -6.56M | -12.17M | -5.99M | -5.76M | -5.14M | -3.73M | -5.61M | -5.67M | -4.67M | -5.33M | -4.72M | -3.65M | -8.49M | -9.89M | -2.14M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.19 | - | - | -0.16 | -0.16 | -0.14 | - | -0.13 | -0.13 | - | - | - | -1.97 | - | - | -0.47 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 475.25K | 605.90K | 897.34K | 1.01M | 895.35K | 1.31M | 20.39K | 2.30M | 11.32M | 18.09M | 18.85M | 801.27K | 73.07K |
| Gross Profit | 238.98K | 349.85K | 470.36K | 527.38K | 454.93K | 703.90K | -225.11K | 363.59K | 3.92M | 5.92M | 5.57M | -119.80K | 16.90K |
| Operating Income | 618 | -27.88K | 18.90K | -50.00K | -157.21K | 66.67K | -4.49M | -17.66M | -29.08M | -21.39M | -15.29M | -9.90M | -14.19M |
| Net Income | - | -30.09K | 19.15K | -48.85K | -147.53K | 68.21K | -5.14M | -28.67M | -29.05M | -21.69M | -21.00M | -23.76M | -25.23M |
| Diluted EPS | - | - | - | - | - | 0.01 | -0.04 | -1.06 | -1.02 | - | - | -17.68 | -11.97 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 95.72K | 166.71K | 239.75K | 355.33K | 241.03K | 408.30K | 605.31K | 9.23M | 16.39M | 17.30M | 9.90M | 2.76M | 965.69K |
| Total Equity | -90.32K | -59.65K | -20.64K | -1.49K | 39.67K | -72.86K | -7.83M | -9.76M | -9.35M | 8.87M | 9.32M | -5.61M | -18.63M | -15.30M |
| Cash & Equivalents | - | - | - | - | - | - | 938.04K | 42.64K | 380.00K | 4.18M | 4.43M | 379.98K | 13.79K | 281.44K |
| Long Term Debt | - | 17.78K | 28.77K | 21.17K | 25.30K | 14.01K | 5.50K | 2.06K | 1.24M | 0 | 2.54M | 457.66K | 1.97M | 3.42K |
| Total Liabilities | - | 155.36K | 187.35K | 241.23K | 315.67K | 313.89K | 410.95K | 10.36M | 9.33M | 7.51M | 7.98M | 15.50M | 21.39M | 16.27M |
| Current Liabilities | - | 137.58K | 158.58K | 220.06K | 290.36K | 299.88K | 405.46K | 10.28M | 5.42M | 6.48M | 4.97M | 14.75M | 19.37M | 16.26M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -35.65K | 1.22K | 13.07K | 32.11K | -17.60K | 62.39K | -2.66M | -21.32M | -14.70M | -14.04M | -10.19M | -7.30M | -4.82M |
| Investing Cash Flow | - | -30.39K | -20.59K | -52.08K | -42.23K | -67.57K | -12.55K | -768.62K | 0 | -102.70K | -14.11K | -3.23K | - |
| Financing Cash Flow | 28.97K | 53.41K | -10.05K | 74.28K | 16.09K | -5.76K | 1.78M | 22.49M | 19.01M | 14.45M | 6.15M | 7.54M | 5.10M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 50.3% | 57.7% | 52.4% | 52.1% | 50.8% | 53.8% | -1,104.2% | 15.8% | 34.6% | 32.7% | 29.5% | -15.0% | 23.1% |
| Operating Margin % | 0.1% | -4.6% | 2.1% | -4.9% | -17.6% | 5.1% | -22,009.4% | -767.9% | -257.0% | -118.3% | -81.1% | -1,235.6% | -19,415.6% |
| Net Margin % | - | -5.0% | 2.1% | -4.8% | -16.5% | 5.2% | -25,191.2% | -1,246.7% | -256.7% | -119.9% | -111.4% | -2,964.9% | -34,537.0% |
| ROE % | - | 145.8% | -1,289.8% | -123.1% | 202.5% | -0.9% | 52.6% | 306.7% | -327.4% | -232.7% | 374.7% | 127.5% | 164.9% |
| ROCE % | -1.5% | -342.7% | 96.0% | -77.0% | 267.1% | 2,348.5% | 46.4% | -463.5% | -293.6% | -173.4% | 315.1% | 59.6% | 92.8% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for SBEV
Splash's CannEpil Program Is Expected to Target Cancer and Pain in Dogs - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxNVlF2b2N4a05ZN0ZxZnVGTVM4M19VN3l5cVQxOThnakdhZjVuMmFfM1NVSjYzelRMQkEtLWJlMkVOemV1aGNRRVBKT0NnZUxHNmNBMFJhbWFYRlVhcUxsWUg4UEU5RHRNZnBoamVYSWdLNnRxdmM0d3U2SkcxeUxJM1I5RVJ0N0VVZUEyOE…
Splash Beverage Group (SBEV) Stock Is Trending Overnight— Here's Why It Jumped 64% After Hours - Sahm
<a href="https://news.google.com/rss/articles/CBMi2AFBVV95cUxQcnRvOTB6Vm53eXlNejh4c0F3YmFDODB6QkVxNnN1WU1hS3hKRjJTVnBSLVY1ekNxeEtTckZWRWY5eHdnVHA2NEhzNDJwTmZJcnBLVmVtWm43a3lXUU8yc0M3OFhjWWNXOEt1b0ppQTFqa2o3TUtQdkVjM1NLSXlCY2llZTg0Z0dwMEl2YU…
Splash Beverage announces reverse stock split, settlement with creditors (SBEV:NYSE) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxOSHQ3OUN2NGg1c1gtLXBSM1lXQUhYdXE5akhoaHhsTDVrQjdoX09Td3pMWklTZXRhUzd6OEZrMzRYNFhBTWRmTGZOaDZRbkxLMF9QRkJZaVlYX25YckVaWWtPWnVJRndqamNHY2JyUVJVXzN5ODFjcVFnNzAtOU9JbzJwWTVPZldmMnJDaz…
SBEV Stock Tumbles Over 35% In Pre-Market Today — A Look At Its Latest Deal With Argent BioPharma - Stocktwits
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxOeTRzdDNzYi1WeWJESDRhd1BCVnRnWGJMMlAtblFTR0w0a1gxRi1XOVplc3JrV25SamZERUtaNXoxTkVYbEN2LW1wRjZIdGFCaS1MalQ1b3pQaTdoay1pSFpuSi1wVGFqLW05MU9FLWVBd2xMbzMyUGhFMjVBaWw5ZzRJLUQ1YWtkb2Q4VV…
Splash Beverage Group Announces Significant Balance Sheet Improvement and Board Approval of Reverse Stock Split as Company Continues Strategic Transformation - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxQN3ZDN3BBcnVjVzZSdUFJdm0zVmk3QkF6bjc1UjZKLUJQZ2RhNUFoR0hvYmYxQTFWdE9hMnhEdXJoUllUN0puRk84SHd3d3J1VTZJY19WN0tTRGFuN0lVUm03ZDdNWDJ5UkNuMmtXTUtzZk9KSnZtTjVIQTZ0MEJVWGlQMjlTS1hNZmo1eU…
SBEV Stock Surge: Buy Now or Wait? - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxQeXJ0YWdxZ2xyb0V4czRiYXRwRUZuZXktSWctWVozazhUV3FoWXh6SWJ2TEZXSmc1YXA5LTNXLUFRVU9IVnlfYUxTY0JZLWFTZVZxcEZaUzdfeU1UcERGNzc4aGs2V2lnOTJoUnFuTTZMSkpMYTFYMVladXBrdXNmUHpUbFViU0hN?oc=5"…
SBEV — Frequently Asked Questions
What is the current share price of SBEV?
As of 2026-08-05 17:25 PDT, SBEV trades at $0.42 on NASDAQ/NYSE. Its 52-week range is $0.32 to $10.16.
What is the P/E ratio of SBEV?
SBEV trades at a trailing price-to-earnings (P/E) ratio of -0.04.
Is SBEV a good stock to buy?
This page provides a data-driven analysis of SBEV, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.